DOW JONES22,261.38+1208.85 5.74%
S&P 5002,626.02+137.37 5.52%
NASDAQ7,827.77+454.69 6.17%

Baird Maintains Neutral on Mednax, Lowers Price Target to $21

Baird maintains Mednax (NYSE:MD) with a Neutral and lowers the price target from $24 to $21.

Benzinga · 03/03/2020 13:55

Baird maintains Mednax (NYSE:MD) with a Neutral and lowers the price target from $24 to $21.